Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
58
MMSI Quote, Financials, Valuation and Earnings
Last price:
$87.38
Seasonality move
:
2.52%
Day range:
$86.97 - $87.99
52-week range:
$78.12 - $111.45
Dividend yield:
0%
P/E ratio:
44.73x
P/S ratio:
3.59x
P/B ratio:
3.39x
Volume:
196.9K
Avg. volume:
670.4K
1-year change:
-10.9%
Market cap:
$5.2B
Revenue:
$1.4B
EPS (TTM):
$1.95
Analysts' Opinion
-
Consensus RatingMerit Medical Systems, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $103.60, Merit Medical Systems, Inc. has an estimated upside of 18.55% from its current price of $87.39.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $90.00 representing 100% downside risk from its current price of $87.39.
Fair Value
-
According to the consensus of 5 analysts, Merit Medical Systems, Inc. has 18.55% upside to fair value with a price target of $103.60 per share.
MMSI vs. S&P 500
-
Over the past 5 trading days, Merit Medical Systems, Inc. has underperformed the S&P 500 by -1.23% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Merit Medical Systems, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Merit Medical Systems, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter Merit Medical Systems, Inc. reported revenues of $384.3M.
Earnings Growth
-
Merit Medical Systems, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Merit Medical Systems, Inc. reported earnings per share of $0.46.
Enterprise value:
5.6B
EV / Invested capital:
2.39x
Price / LTM sales:
3.59x
EV / EBIT:
31.07x
EV / Revenue:
3.80x
PEG ratio (5yr expected):
2.45x
EV / Free cash flow:
27.52x
Price / Operating cash flow:
25.99x
Enterprise value / EBITDA:
17.95x
Gross Profit (TTM):
$715.7M
Return On Assets:
4.74%
Net Income Margin (TTM):
8.03%
Return On Equity:
8.28%
Return On Invested Capital:
5.28%
Operating Margin:
11.13%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.2B | $1.3B | $1.5B | $339.1M | $384.3M | |
| Gross Profit | $519.7M | $603M | $715.7M | $156.6M | $186.5M | |
| Operating Income | $119.7M | $149.6M | $180.5M | $36.4M | $42.8M | |
| EBITDA | $217.7M | $259M | $312.4M | $65.8M | $77M | |
| Diluted EPS | $1.72 | $2.04 | $1.95 | $0.48 | $0.46 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $463.4M | $499.9M | $585.3M | $1.1B | $985.5M | |
| Total Assets | $1.6B | $1.6B | $1.8B | $2.4B | $2.6B | |
| Current Liabilities | $213.5M | $213M | $187.1M | $201.1M | $230.5M | |
| Total Liabilities | $629.8M | $543.9M | $578.6M | $1.1B | $1.1B | |
| Total Equity | $1B | $1.1B | $1.2B | $1.3B | $1.5B | |
| Total Debt | $342.2M | $276.7M | $343.6M | $807.7M | $810.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $110.9M | $214.3M | $267.6M | $47.3M | $75M | |
| Cash From Investing | -$184.3M | -$162.5M | -$411.5M | -$115.7M | -$24.1M | |
| Cash From Financing | $80.7M | $410.4M | $13.4M | -$47.6M | -$365K | |
| Free Cash Flow | $68.2M | $172.7M | $203.8M | $37.4M | $51.5M | |
MMSI
Sector
Market Cap
$5.2B
$28M
Price % of 52-Week High
78.41%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
-0.76%
-1.54%
1-Year Price Total Return
-10.9%
-17.48%
Beta (5-Year)
0.615
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$87.33
200-day SMA
Sell
Level
$89.85
Bollinger Bands (100)
Buy
Level
82.48 - 88.52
Chaikin Money Flow
Buy
Level
120.2M
20-day SMA
Buy
Level
$86.02
Relative Strength Index (RSI14)
Buy
Level
57.33
ADX Line
Buy
Level
13.38
Williams %R
Neutral
Level
-33.1915
50-day SMA
Buy
Level
$85.50
MACD (12, 26)
Buy
Level
0.60
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
111.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.8073)
Buy
CA Score
(Annual)
Level (0.2588)
Buy
Beneish M-Score
(Annual)
Level (-2.5259)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.22)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Stock Forecast FAQ
In the current month, MMSI has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The MMSI average analyst price target in the past 3 months is $103.60.
-
Where Will Merit Medical Systems, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Merit Medical Systems, Inc. share price will rise to $103.60 per share over the next 12 months.
-
What Do Analysts Say About Merit Medical Systems, Inc.?
Analysts are divided on their view about Merit Medical Systems, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Merit Medical Systems, Inc. is a Sell and believe this share price will drop from its current level to $90.00.
-
What Is Merit Medical Systems, Inc.'s Price Target?
The price target for Merit Medical Systems, Inc. over the next 1-year time period is forecast to be $103.60 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is MMSI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Merit Medical Systems, Inc. is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MMSI?
You can purchase shares of Merit Medical Systems, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Merit Medical Systems, Inc. shares.
-
What Is The Merit Medical Systems, Inc. Share Price Today?
Merit Medical Systems, Inc. was last trading at $87.38 per share. This represents the most recent stock quote for Merit Medical Systems, Inc.. Yesterday, Merit Medical Systems, Inc. closed at $87.39 per share.
-
How To Buy Merit Medical Systems, Inc. Stock Online?
In order to purchase Merit Medical Systems, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MMSI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MMSI
Sector
P/E ratio
44.73x
23.89x
PEG ratio
2.45x
-0.01x
P/B ratio
3.39x
1.82x
Price / LTM sales
3.59x
1.60x
Growth Metrics
MMSI
Sector
Revenue growth
13.31%
4.62%
Earnings growth
-3.06%
10.88%
Revenue (5-year growth)
6.38%
6.5%
Earnings forecast
$0.83
-$0.21
Profitability
MMSI
Sector
Profitability FY 2024
$640.5M
$3.5M
Return on invested capital
5.28%
-31.77%
Return on assets
4.74%
-27.96%
Return on equity
8.28%
-37.63%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Jan
29
Balance Sheet
MMSI
Sector
Total cash
$394.6M
$26.3M
Short term investments
--
$25.7M
Total assets
$2.4B
$78M
Long term debt
$810.5M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
